Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Published in: Inflammation Research 1/2012

Open Access 01-01-2012 | Original Research Paper

C-reactive protein haplotypes and dispositional optimism in obese and nonobese elderly subjects

Authors: Nathaly Rius-Ottenheim, Anton J. M. de Craen, Johanna M. Geleijnse, P. Eline Slagboom, Daan Kromhout, Roos C. van der Mast, Frans G. Zitman, Rudi G. Westendorp, Erik J. Giltay

Published in: Inflammation Research | Issue 1/2012

Login to get access

Abstract

Background

Chronic low-grade inflammation, characterized by elevated plasma levels of C-reactive protein (CRP), has been inversely associated with dispositional optimism. Using a Mendelian randomization design, this study explores whether CRP haplotypes that determine CRP plasma levels are also associated with dispositional optimism.

Methods

In a sample of 1,084 community-dwelling subjects (aged 60–85 years) from three cohort studies (Arnhem Elderly Study, n = 426; Leiden Longevity Study, n = 355; Zutphen Elderly Study, n = 303), six CRP polymorphisms (rs2808628, rs2808630, rs1205, rs1800947, rs1417938, and rs3091244) coding for five common haplotypes were genotyped. The association of CRP haplotypes with CRP plasma levels and dispositional optimism was analyzed using multivariable linear regression models. Subanalyses were stratified by body mass index (BMI ≥25 kg/m2).

Results

CRP haplotypes determined CRP plasma levels (adjusted β = 0.094, p < 0.001). In the whole group, no association was found between CRP haplotypes and dispositional optimism scores (adjusted β = −0.02, p = 0.45). In BMI strata, CRP haplotypes were associated with increasing levels of plasma CRP levels (adjusted β = 0.112; p = 0.002) and lower dispositional optimism levels (adjusted β = −0.068; p = 0.03) in the obese group only.

Conclusions

These results suggest that genetically increased CRP levels are involved in low dispositional optimism, but only in case of obesity.
Literature
1.
Ranjit N, Diez-Roux A, Shea S, Cushman M, Seeman T, Jackson S, et al. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med. 2007;167(2):174–81.PubMedCrossRef
2.
Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007;21(7):901–12.PubMedCrossRef
3.
Carney R, Freedland K, Miller G, Jaffe A. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res. 2002;53(4):897–902.PubMedCrossRef
4.
Bremmer M, Beekman A, Deeg D, Penninx B, Dik M, Hack C, et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008;106(3):249–55.PubMedCrossRef
5.
Danner M, Kasl S, Abramson J, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med. 2003;65(3):347–56.PubMedCrossRef
6.
Ford D, Erlinger T. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004;164(9):1010–4.PubMedCrossRef
7.
Kop W, Gottdiener J, Tangen C, Fried L, McBurnie M, Walston J, et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89(4):419–24.PubMedCrossRef
8.
Penninx B, Kritchevsky S, Yaffe K, Newman A, Simonsick E, Rubin S, et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry. 2003;54(5):566–72.PubMedCrossRef
9.
Friedman E, Hayney M, Love G, Singer B, Ryff C. Plasma interleukin-6 and soluble IL-6 receptors are associated with psychological well-being in aging women. Health Psychol. 2007;26(3):305–13.PubMedCrossRef
10.
Janicki-Deverts D, Cohen S, Doyle W, Turner R, Treanor J. Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect. Brain Behav Immun. 2007;21(3):301–7.PubMedCrossRef
11.
Roy B, Diez-Roux A, Seeman T, Ranjit N, Shea S, Cushman M. Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA). Psychosom Med. 2010;72(2):134–40.PubMedCrossRef
12.
Steptoe A, Wardle J, Marmot M. Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes. Proc Natl Acad Sci USA. 2005;102(18):6508–12.PubMedCrossRef
13.
Scheier M, Carver C, Bridges M. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test. J Pers Soc Psychol. 1994;67(6):1063–78.PubMedCrossRef
14.
15.
Giltay E, Geleijnse J, Zitman F, Hoekstra T, Schouten E. Dispositional optimism and all-cause and cardiovascular mortality in a prospective cohort of elderly dutch men and women. Arch Gen Psychiatry. 2004;61(11):1126–35.PubMedCrossRef
16.
Giltay E, Kamphuis M, Kalmijn S, Zitman F, Kromhout D. Dispositional optimism and the risk of cardiovascular death: the Zutphen Elderly Study. Arch Intern Med. 2006;166(4):431–6.PubMedCrossRef
17.
Tindle H, Chang Y, Kuller L, Manson J, Robinson J, Rosal M, et al. Optimism, cynical hostility, and incident coronary heart disease and mortality in the women’s health initiative. Circulation. 2009;120(8):656–62.PubMedCrossRef
18.
Brydon L, Walker C, Wawrzyniak A, Chart H, Steptoe A. Dispositional optimism and stress-induced changes in immunity and negative mood. Brain Behav Immun. 2009;23(6):810–6.PubMedCrossRef
19.
Visser M, Bouter L, McQuillan G, Wener M, Harris T. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131–5.PubMedCrossRef
20.
Festa A, D’Agostino RJ, Williams K, Karter A, Mayer-Davis E, Tracy R, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25(10):1407–15.PubMedCrossRef
21.
Tchernof A, Nolan A, Sites C, Ades P, Poehlman E. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 2002;105(5):564–9.PubMedCrossRef
22.
Eiriksdottir G, Smith A, Aspelund T, Hafsteinsdottir S, Olafsdottir E, Launer L, et al. The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibilty-Reykjavik study. Int J Obes (Lond). 2009;33(2):267–72.CrossRef
23.
Lawlor D, Harbord R, Sterne J, Timpson N, Smith DG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.PubMedCrossRef
24.
Smith G, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30–42.PubMedCrossRef
25.
Bochud M, Rousson V. Usefulness of Mendelian randomization in observational epidemiology. Int J Environ Res Public Health. 2010;7(3):711–28.PubMedCrossRef
26.
Sheehan N, Didelez V, Burton P, Tobin M. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008;5(8):e177.PubMedCrossRef
27.
Lange L, Carlson C, Hindorff L, Lange E, Walston J, Durda J, et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA. 2006;296(22):2703–11.PubMedCrossRef
28.
Carlson C, Aldred S, Lee P, Tracy R, Schwartz S, Rieder M, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77(1):64–77.PubMedCrossRef
29.
Crawford D, Sanders C, Qin X, Smith J, Shephard C, Wong M, et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation. 2006;114(23):2458–65.PubMedCrossRef
30.
Szalai A, McCrory M, Cooper G, Wu J, Kimberly R. Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun. 2002;3(1):14–9.PubMedCrossRef
31.
Hage F, Szalai A. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 2007;50(12):1115–22.PubMedCrossRef
32.
Kathiresan S, Larson M, Vasan R, Guo C, Gona P, Keaney JJ, et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation. 2006;113(11):1415–23.PubMedCrossRef
33.
Bos S, Suchiman H, Kloppenburg M, Houwing-Duistermaat J, le Graverand M, Seymour A, et al. Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C-reactive protein levels in the GARP study. Ann Rheum Dis. 2008;67(6):877–9.PubMedCrossRef
34.
Timpson N, Nordestgaard B, Harbord R, Zacho J, Frayling T, Tybjaerg-Hansen A, et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond). 2011;35(2):300–8.CrossRef
35.
Halder I, Marsland A, Cheong J, Muldoon M, Ferrell R, Manuck S. Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun. 2010;24(1):160–7.PubMedCrossRef
36.
Almeida O, Norman P, Allcock R, van Bockxmeer F, Hankey G, Jamrozik K, et al. Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the health in men study. Int J Epidemiol. 2009;38(4):1049–59.PubMedCrossRef
37.
Feskens E, Bloemberg B, Pijls L, Kromhout D. A longitudinal study on elderly men: the Zutphen Study. In: Schroots JJF, editor. Aging, Health and Competence. Amsterdam: Elsevier Science; 1993.
38.
Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, Blauw GJ, Slagboom PE, et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet. 2006;14(1):79–84.PubMed
39.
van den Hombergh CE, Schouten EG, van Staveren WA, van Amelsvoort LG, Kok FJ. Physical activities of noninstitutionalized Dutch elderly and characteristics of inactive elderly. Med Sci Sports Exerc. 1995;27(3):334–9.
40.
Giltay E, Geleijnse J, Zitman F, Hoekstra T, Schouten E. Dispositional optimism and all-cause and cardiovascular mortality in a prospective cohort of elderly dutch men and women. Arch Gen Psychiatry. 2004;61(11):1126–35.PubMedCrossRef
41.
Tempelman C (1987) Well-being in the elderly: development of the Scale Subjective Well-being in Older persons. University of Groningen.
42.
Sweat V, Starr V, Bruehl H, Arentoft A, Tirsi A, Javier E, et al. C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation. 2008;31(3):198–207.PubMedCrossRef
43.
Brull D, Serrano N, Zito F, Jones L, Montgomery H, Rumley A, et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23(11):2063–9.PubMedCrossRef
44.
Russell A, Cunninghame Graham D, Shepherd C, Roberton C, Whittaker J, Meeks J, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet. 2004;13(1):137–47.PubMedCrossRef
45.
Steptoe A, O’Donnell K, Badrick E, Kumari M, Marmot M. Neuroendocrine and inflammatory factors associated with positive affect in healthy men and women: the Whitehall II study. Am J Epidemiol. 2008;167(1):96–102.PubMedCrossRef
46.
Fried S, Bunkin D, Greenberg A. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83(3):847–50.PubMedCrossRef
47.
Bastard J, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation. 1999;99(16):2221–2.PubMed
48.
Giltay E, Geleijnse J, Zitman F, Buijsse B, Kromhout D. Lifestyle and dietary correlates of dispositional optimism in men: the Zutphen Elderly Study. J Psychosom Res. 2007;63(5):483–90.PubMedCrossRef
49.
Hayley S, Poulter M, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience. 2005;135(3):659–78.PubMedCrossRef
50.
Costanzo E, Lutgendorf S, Kohut M, Nisly N, Rozeboom K, Spooner S, et al. Mood and cytokine response to influenza virus in older adults. J Gerontol A Biol Sci Med Sci. 2004;59(12):1328–33.PubMedCrossRef
Metadata
Title
C-reactive protein haplotypes and dispositional optimism in obese and nonobese elderly subjects
Authors
Nathaly Rius-Ottenheim
Anton J. M. de Craen
Johanna M. Geleijnse
P. Eline Slagboom
Daan Kromhout
Roos C. van der Mast
Frans G. Zitman
Rudi G. Westendorp
Erik J. Giltay
Publication date
01-01-2012
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 1/2012
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-011-0387-5

Other articles of this Issue 1/2012

Inflammation Research 1/2012 Go to the issue

Original Research Paper

The effects of leflunomide on CD4+CD25+Foxp3+ T regulatory cells in mice receiving allogeneic bone marrow transplantation

Review

Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases

Original Research Paper

C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia

Original Research Paper

Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulation

Original Research Paper

Protective effects of IL-4 on Bacillus Calmette-Guerin and lipopolysaccharide induced immunological liver injury in mice

Original Research Paper

Di-(2-ethylhexyl) phthalate induces production of inflammatory molecules in human macrophages
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits